KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ONCE
Delisted

Spark Therapeutics Stock Price (Quote)

$113.57
+0 (+0%)
At Close: Jan 24, 2020

Range Low Price High Price Comment
30 days $113.57 $113.57 Friday, 24th Jan 2020 ONCE stock ended at $113.57. During the day the stock fluctuated 0% from a day low at $113.57 to a day high of $113.57.
90 days $108.00 $113.90
52 weeks $40.64 $114.20

Historical Spark Therapeutics prices

Date Open High Low Close Volume
Jan 24, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 23, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 22, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 21, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 17, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 16, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 15, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 14, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 13, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 10, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 09, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 08, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 07, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 06, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 03, 2020 $113.57 $113.57 $113.57 $113.57 0
Jan 02, 2020 $113.57 $113.57 $113.57 $113.57 0
Dec 31, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 30, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 27, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 26, 2019 $113.57 $113.57 $113.57 $113.57 8 720
Dec 24, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 23, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 20, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 19, 2019 $113.57 $113.57 $113.57 $113.57 0
Dec 18, 2019 $113.57 $113.57 $113.57 $113.57 0
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT